Clinical efficacy of eperisone in the treatment of patients with musculoskeletal pain
- 1 July 2026
- journal article
- Published by Media Sphere Publishing Group in Russian Journal of Pain
- Vol. 24 (2)
Abstract
Objective. To study the clinical efficacy and safety of epirisone hydrochloride (Stezium) in the treatment of patients with skeletal muscle pain. Material and methods. One hundred forty-two 142 patients with non-specific musculoskeletal pain, mean age 46.2±17.8 years, have been enrolled in the study. The study was conducted according to the registered indication for Stezium — diseases of the musculoskeletal system accompanied by painful muscle spasms. Patients received Stezium 75 mg, extended-release, film-coated tablets, twice a day after meals for 14 days. All patients had undergone clinical examination before the prescription of the drug and on the 15th day using a visual analogue scale (VAS), a verbal analogue scale for pain assessing, a visual analogue scale (EQ-VAS) for the European Quality of Life Questionnaire (EQ-5D-3L), and patient assessment of the treatment effectiveness with Likert scale. Results. Quantitative indicators of pain assessment using analog scales statistically significant decreased (p<0.001) against the background of the treatment with Stezium, which indicates a significant analgesic effect of the therapy. Analysis of patient’s health condition showed an increase in the quality of life (from 60.22±10.45 to 74.11±11.53 points; p<0.001), which confirms the effectiveness of the performed therapy. The patient’s assessment of the overall treatment effect on the Likert scale demonstrated positive trend — 85.21% of patients noted significant clinical effect. Conclusion. The study results demonstrated the clinical efficacy and safety of extended-release film-coated tablets eperisone hydrochloride 75 mg for the treatment of musculoskeletal pain.Keywords
This publication has 24 references indexed in Scilit:
- Analgesic effects of non-surgical and non-interventional treatments for low back pain: a systematic review and meta-analysis of placebo-controlled randomised trialsBMJ Evidence-Based Medicine, 2025
- Comparative effectiveness and safety of analgesic medicines for adults with acute non-specific low back pain: systematic review and network meta-analysisBMJ, 2023
- Prevalence, Incidence, and Factors Associated With Non-Specific Chronic Low Back Pain in Community-Dwelling Older Adults Aged 60 Years and Older: A Systematic Review and Meta-AnalysisThe Journal of Pain, 2022
- Trajectories of disability in low back painPain Reports, 2022
- Domains of Chronic Low Back Pain and Assessing Treatment Effectiveness: A Clinical PerspectivePain Practice, 2019
- Clinical efficacy and safety of eperisone for low back pain: A systematic literature reviewPharmacological Reports, 2016
- What have we learned from ten years of trajectory research in low back pain?BMC Musculoskeletal Disorders, 2016
- Musculoskeletal disorders and the Global Burden of Disease studyAnnals of the Rheumatic Diseases, 2014
- The Effect of Muscle Relaxant on the Paraspinal Muscle Blood FlowSpine, 2008
- Post-traumatic myofascial pain of the head and neck.Current Pain and Headache Reports, 2002